Metagenomics Global Market Report 2024: Robust Growth Projected with AI Integration and Precision Medicine Advances by 2028 - Forecasts to 2033


Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Metagenomics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.

The global metagenomics market is poised for unprecedented growth, with a leap from $1.72 billion in 2023 to a forecasted $3.43 billion by 2028. This surge represents a compound annual growth rate (CAGR) of 14.5%, propelled by the integration of metagenomics in precision medicine, innovative technologies, and widespread applications ranging from clinical diagnostics to environmental monitoring. A newly published metagenomics market research report, now available on our website, affords an in-depth review of this dynamic sector, highlighting key market drivers, trends, and opportunities shaping the industry.

Technological advancements are at the forefront of the market's growth trajectory, with major market players deploying cutting-edge sequencing methods and artificial intelligence for enhanced metagenomic analysis. Single-cell metagenomics and standardization of metagenomic data further underscore the evolution of the industry, as stakeholders harness the power of data analytics to facilitate groundbreaking research and development.

Among the sectors catalyzing the rise of the metagenomics market, infectious disease research stands out. With the escalation of global health threats, including the tuberculosis epidemic, metagenomics provides essential insights into the pathogenic landscapes, aiding in the control and prevention of worldwide health crises. Additionally, the agriculture sector's growth underscores the significance of microbial genomics in optimizing crop yields, managing soil health, and ensuring sustainable agricultural practices.

In alignment with these advancements, the addition to our website provides a comprehensive overview of the notable trends and growth indicators. The report segments the metagenomics market into instruments, kits and reagents, and software and services, examining their applications across environmental, clinical, pharmaceutical, biotechnological, and nutritional landscapes. It features vital insights into end-user dynamics and regional market analysis, with North America leading in market share and Asia-Pacific projected to be the fastest-growing region.

Within the document, readers will find a well-rounded examination of the metagenomics market, including detailed analyses of key players and geographic market share distribution. The report's thorough approach equips stakeholders with the actionable intelligence necessary to navigate the complexities of the metagenomics landscape and harness its growth potential efficiently.

As the industry continues to evolve, this publication serves as a pivotal resource for those looking to understand the market's direction and the strategic moves of leading entities. The informative content within the report aims to guide research institutes, pharmaceutical industries, biotechnology companies, and healthcare providers through the ever-expanding metagenomics domain.

The collective advancement of genomic sciences and their applications in various fields underscores the relevance and timely nature of this comprehensive metagenomics market research report. Interested parties are encouraged to explore the full spectrum of data and strategic insights now accessible on our website to stay abreast of this rapidly expanding market.

A selection of companies mentioned in this report includes

  • Illumina Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Perkin Elmer Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novogene Co. Ltd.
  • Oxford Nanopore Technologies Limited
  • Takara Bio USA Inc.
  • BGI Group
  • Eurofins Scientific SE
  • Arc Bio LLC
  • Computomics GmbH
  • Enterome Bioscience
  • TAKARA BIO INC.
  • Danaher Corporation
  • ELITechGroup
  • Metagenomi
  • Cosmosid Inc.
  • Pattern Ag
  • Tiny Health
  • MATIS OHF
  • Adapsyn Bioscience
  • Precidiag Inc.
  • One Codex Inc.
  • MetaBi Inc.
  • Zymo Research Corporation
  • Bluebee Holding BV
  • Maverix Biomics Inc.
  • Lucigen Corporation

For more information about this report visit https://www.researchandmarkets.com/r/kw1mhj

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data